ZP2495 Protects against Myocardial Ischemia/Reperfusion Injury in Diabetic Mice through Improvement of Cardiac Metabolism and Mitochondrial Function: The Possible Involvement of AMPK‐FoxO3a Signal Pathway
Open Access
- 17 January 2018
- journal article
- research article
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2018 (1) , 6451902
Abstract
Coronary heart disease patients with type 2 diabetes were subject to higher vulnerability for cardiac ischemia‐reperfusion (I/R) injury. This study was designed to evaluate the impact of ZP2495 (a glucagon‐GLP‐1 dual‐agonist) on cardiac function and energy metabolism after myocardial I/R injury in db/db mice with a focus on mitochondrial function. C57BLKS/J‐lepr+/lepr+(BKS) and db/db mice received 4‐week treatment of glucagon, ZP131 (GLP‐1 receptor agonist), or ZP2495, followed by cardiac I/R injury. The results showed that cardiac function, cardiac glucose metabolism, cardiomyocyte apoptosis, cardiac mitochondrial morphology, and energetic transition were improved or ameliorated by ZP2495 to a greater extent than that of glucagon and ZP131.In vitrostudy showed that ZP2495, rather than glucagon, alleviated mitochondrial depolarization, cytochrome C release, and mitochondria ROS generation in neonatal rat ventricular myocytes subjected to high‐glucose and simulated I/R injury conditions, the effects of which were weaker in the ZP131 group. Furthermore, the expressions of Akt, FoxO3a, and AMPK phosphorylation were elevated by ZP2495 to a greater extent than that of ZP131. In conclusion, ZP2495 may contribute to the improvement of cardiac function and energy metabolism in db/db mice after myocardial I/R injury by improving mitochondrial function possibly through Akt/FoxO3a and AMPK/FoxO3a signal pathways.Keywords
Funding Information
- Natural Science Foundation of Beijing Municipality (7152131)
- National Natural Science Foundation of China (81570272, 81530058, 81300149, 81270168)
- China National Funds for Distinguished Young Scientists (81325009)
This publication has 51 references indexed in Scilit:
- Luteolin Limits Infarct Size and Improves Cardiac Function after Myocardium Ischemia/Reperfusion Injury in Diabetic RatsPLOS ONE, 2012
- Glucagon and a glucagon‐GLP‐1 dual‐agonist increases cardiac performance with different metabolic effects in insulin‐resistant heartsBritish Journal of Pharmacology, 2011
- Mitochondrial oxidant stress triggers cell death in simulated ischemia–reperfusionBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- A Novel and Efficient Model of Coronary Artery Ligation and Myocardial Infarction in the MouseCirculation Research, 2010
- Incretin-Based Therapies for the Treatment of Type 2 Diabetes: Evaluation of the Risks and BenefitsDiabetes Care, 2010
- Glycogen Synthase Kinase 3 Inhibition Protects the Heart From Acute Ischemia-Reperfusion Injury Via Inhibition of Inflammation and ApoptosisJournal of Cardiovascular Pharmacology, 2008
- FoxO transcription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phosphatasesProceedings of the National Academy of Sciences, 2007
- An AMPK-FOXO Pathway Mediates Longevity Induced by a Novel Method of Dietary Restriction in C. elegansCurrent Biology, 2007
- Adiponectin Cardioprotection After Myocardial Ischemia/Reperfusion Involves the Reduction of Oxidative/Nitrative StressCirculation, 2007
- Reperfusion injury induces apoptosis in rabbit cardiomyocytes.Journal of Clinical Investigation, 1994